biotechnology
16 articles about biotechnology in AI news
The Coming Revolution: How AI-Powered Biotech Could Make Aging Obsolete Within Two Decades
Harvard geneticist David Sinclair predicts biotechnology advances will transform healthcare within 10-20 years, shifting from treating diseases to preventing and reversing aging itself through AI-driven biological control.
Sam Altman Predicts 'One-Person Billion-Dollar Companies' as AI Reshapes Business Scale
OpenAI CEO Sam Altman predicts the emergence of 'one-person billion-dollar companies' powered by AI, citing a specific example from a private CEO discussion group. This follows his earlier forecast of 10-person billion-dollar firms, suggesting AI is accelerating the compression of business scale.
Nature Report: China's Public R&D Spending Nears US Levels, Shifting Global Science Funding Landscape
A new Nature report indicates China is close to surpassing the US in public R&D spending. This shift in funding could alter which nation sets the global pace for scientific research, though China still lags in fundamental research output.
Neurons Playing Doom: How Living Brain Cells Could Revolutionize Computing
Australian startup Cortical Labs is pioneering biological computing with a system that uses living human brain cells to perform computational tasks. Their CL1 computer consumes just 30 watts while learning to play Doom, potentially offering massive energy savings over traditional AI hardware.
Anthropic Challenges U.S. Government in Dual Lawsuits Over AI Research Restrictions
AI safety company Anthropic has filed lawsuits in two separate federal courts challenging U.S. government restrictions that have placed its research lab on an export blacklist. The legal action represents a significant confrontation between AI developers and regulatory authorities over research transparency and national security concerns.
Safety Gap: OpenAI's Most Powerful AI Models Released Without Critical Risk Assessments
OpenAI's GPT-5.4 Pro, potentially the world's most capable AI for high-risk tasks like bioweapons research and cyber operations, has been released without published safety evaluations or system cards, continuing a concerning pattern with 'Pro' model releases.
China's Semiconductor Leaders Rally for National AI Chip Alliance Amid Tech War Escalation
China's top semiconductor executives have issued an unprecedented public call for a consolidated national effort to build AI chips, signaling a strategic shift toward self-reliance as U.S. export controls tighten. This coordinated push represents China's most direct response yet to technological containment efforts.
The AI IPO Showdown: OpenAI and Anthropic Prepare for Historic Public Debuts
OpenAI and Anthropic are reportedly planning IPOs in 2025, setting the stage for a historic battle between AI giants. Investors appear to be favoring Anthropic's long-term prospects despite OpenAI's current market dominance.
Anthropic CEO Slams OpenAI's Pentagon Deal as 'Safety Theater' in Rare Industry Confrontation
Anthropic CEO Dario Amodei criticized OpenAI's Department of Defense AI partnership as 'safety theater' while revealing the Trump administration's hostility toward his company for refusing 'dictator-style praise.' The comments expose deepening fractures in AI governance approaches.
Top AI Researcher Max Schwarzer Departs OpenAI for Anthropic in Major Industry Shift
Prominent AI researcher Max Schwarzer has left OpenAI to join rival Anthropic, signaling intensifying competition for top talent in the AI sector. The move represents a significant personnel shift between two leading AI labs.
The AI Scare Trade: How Market Fears Are Fueling an Unprecedented M&A Frenzy
A wave of AI-driven disruption is creating an 'AI scare trade' in capital markets, sparking fierce competition between traditional firms and AI startups. This has triggered a surge in mergers and acquisitions as companies race to adapt or acquire the technology reshaping entire industries.
AI Titans Unite: Sam Altman's Public Support for Anthropic Signals Industry-Wide Regulatory Push
OpenAI CEO Sam Altman has publicly declared solidarity with Anthropic amid government scrutiny, signaling unprecedented industry alignment on AI regulation. This coordinated stance could reshape how federal agencies approach oversight of rapidly advancing AI technologies.
FT's AI Risk Chart Sparks Debate: 50% Chance of Human Extinction Versus Abundance
A Financial Times chart showing AI could lead to either human extinction or unprecedented abundance has ignited debate about mainstream recognition of existential risks. The visualization presents a stark 50/50 probability between catastrophic and utopian outcomes.
AI Research Automation Could Arrive by 2027, Raising Security Concerns
New analysis suggests AI systems could fully automate top research teams as early as 2027, potentially accelerating progress in sensitive security domains. This development raises questions about international stability and AI governance.
From $100M to $100: How AI is Driving the Next Diagnostic Revolution
The cost of sequencing a human genome has plummeted from $100 million to under $100 in just 25 years, a milestone powered by AI and automation. This unprecedented price drop signals a coming wave of affordable diagnostic tests that could transform personalized medicine.
From Billion-Dollar Project to Pocket Change: How AI Drove the 10 Million-Fold Drop in Genome Sequencing Costs
The cost of sequencing a human genome has plummeted from $1 billion in 2000 to just $100 today—a 10 million-fold reduction. This unprecedented price collapse, accelerated by AI and automation, is revolutionizing personalized medicine and making genomic data accessible to millions.